High concentrations of commonly used drugs can inhibit the in vitro glucuronidation of bisphenol A and nonylphenol in rats

References

• Allgayer H, Kruis W, Eisenburg J, Paumgartner G. (1984). Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis. Eur J Clin Pharmacol 26(2):275–7.
   Google Scholar
• Bechi N, Ietta F, Romagnoli R, Focardi S, Corsi I, Buffi C, Paulesu L. (2006). Estrogen-like response to p-nonylphenol in human first trimester placenta and BeWo choriocarcinoma cells. Toxicol Sci 93(1):75–81.
   Google Scholar
• Bodey GP, Nance J. (1972). Amoxicillin: in vitro and pharmacological studies. Antimicrob Agents Chemother 1(4):358–62.
   Google Scholar
• Brantmark B, Wahlin-Boll E, Melander A. (1982). Bioavailability of acetylsalicylic acid and salicylic acid from rapid- and slow-release formulations, and in combination with dipyridamol. Eur J Clin Pharmacol 22(4):309–14.
   Google Scholar
• Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. (1995). Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103(6):608–12.
   Google Scholar
• Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. (2005). Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113(4):391–5.
   Google Scholar
• Daidoji T, Inoue H, Kato S, Yokota H. (2003). Glucuronidation and excretion of nonylphenol in perfused rat liver. Drug Metab Dispos 31(8):993–8.
   Google Scholar
• Davis TM, Daly F, Walsh JP, Ilett KF, Beilby JP, Dusci LJ, Barrett PH. (2000). Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes. Br J Clin Pharmacol 49(3):223–30.
   Google Scholar
• De Brabander C, Vervaet C, Gortz JP, Remon JP, Berlo JA. (2000). Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystalline wax. Int J Pharm 208(1–2):81–6.
   Google Scholar
• Elsby R, Maggs JL, Ashby J, Park BK. (2001). Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J Pharmacol Exp Ther 297(1):103–13.
   PubMedGoogle Scholar
• Ethell BT, Anderson GD, Burchell B. (2003). The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol 65(9):1441–9.
   Google Scholar
• Grahnen A, von Bahr C, Lindstrom B, Rosen A. (1979). Bioavailability and pharmacokinetics of cimetidine. Eur J Clin Pharmacol 16(5):335–40.
   Google Scholar
• Guenther K, Heinke V, Thiele B, Kleist E, Prast H, Raecker T. (2002). Endocrine disrupting nonylphenols are ubiquitous in food. Environ Sci Technol 36(8):1676–80.
   Google Scholar
• Haddad S, Blanchette E, Rheault I, Verner M-A. (2009). Pharmacokinetic interactions between bisphenol A and naproxen in humans. The Toxicologist CD—Official Journal of the Society of Toxicology 108(S-1):204, abst 285.
   Google Scholar
• Hanioka N, Naito T, Narimatsu S. (2008). Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 74(1):33–6.
   Google Scholar
• Hjelle JJ, Hazelton GA, Klaassen CD. (1985). Acetaminophen decreases adenosine 3′-phosphate 5′-phosphosulfate and uridine diphosphoglucuronic acid in rat liver. Drug Metab Dispos 13(1):35–41.
   Google Scholar
• Howell SR, Hazelton GA, Klaassen CD. (1986). Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated. J Pharmacol Exp Ther 236(3):610–14.
   Google Scholar
• Hussein Z, Mukherjee D, Lamm J, Cavanaugh JH, Granneman GR. (1994). Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation. J Clin Pharmacol 34(7):754–9.
   Google Scholar
• Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. (2002). Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 17(11):2839–41.
   PubMedGoogle Scholar
• Inoue H, Yuki G, Yokota H, Kato S. (2003). Bisphenol A glucuronidation and absorption in rat intestine. Drug Metab Dispos 31(1):140–4.
   PubMedGoogle Scholar
• Inoue K, Kondo S, Yoshie Y, Kato K, Yoshimura Y, Horie M, Nakazawa H. (2001). Migration of 4-nonylphenol from polyvinyl chloride food packaging films into food simulants and foods. Food Addit Contam 18(2):157–64.
   Google Scholar
• Kawaguchi M, Inoue K, Sakui N, Ito R, Izumi S, Makino T, Okanouchi N, Nakazawa H. (2004). Stir bar sorptive extraction and thermal desorption-gas chromatography-mass spectrometry for the measurement of 4-nonylphenol and 4-tert-octylphenol in human biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 799(1):119–25.
   Google Scholar
• Kiang TK, Ensom MH, Chang TK. (2005). UDP-glucuronosyltransferases and clinical drug–drug interactions. Pharmacol Ther 106(1):97–132.
   Google Scholar
• King C, Tang W, Ngui J, Tephly T, Braun M. (2001). Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61(1):49–53.
   Google Scholar
• Kirchheiner J, Meineke I, Steinbach N, Meisel C, Roots I, Brockmoller J. (2003). Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. Br J Clin Pharmacol 55(1):51–61.
   Google Scholar
• Kuch HM, Ballschmiter K. (2001). Determination of endocrine-disrupting phenolic compounds and estrogens in surface and drinking water by HRGC-(NCI)-MS in the picogram per liter range. Environ Sci Technol 35(15):3201–6.
   Google Scholar
• Kuester RK, Sipes IG. (2007). Prediction of metabolic clearance of bisphenol A (4,4′-dihydroxy-2,2-diphenylpropane) using cryopreserved human hepatocytes. Drug Metab Dispos 35(10):1910–15.
   PubMedGoogle Scholar
• Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. (2000). Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 54(1):154–67.
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–75.
   PubMed Web of Science ®Google Scholar
• Mano Y, Usui T, Kamimura H. (2007). Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes. Eur J Clin Pharmacol 63(2):211–16.
   Google Scholar
• Matthews JB, Twomey K, Zacharewski TR. (2001). In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol 14(2):149–57.
   PubMedGoogle Scholar
• Miller R, Ludden TM. (1993). Bioavailability of controlled release carbamazepine estimated by mixed effect modelling. Eur J Clin Pharmacol 44(3):231–5.
   Google Scholar
• Moffat GJ, Burns A, Van Miller J, Joiner R, Ashby J. (2001). Glucuronidation of nonylphenol and octylphenol eliminates their ability to activate transcription via the estrogen receptor. Regul Toxicol Pharmacol 34(2):182–7.
   Google Scholar
• Morichau-Beauchant M, Houin G, Mavier P, Alexandre C, Dhumeaux D. (1986). Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients. Dig Dis Sci 31(2):113–18.
   Google Scholar
• Mroszczak E, Yee JP, Bynum L. (1988). Absorption of naproxen controlled-release tablets in fasting and postprandial volunteers. J Clin Pharmacol 28(12):1128–31.
   Google Scholar
• Neuvonen PJ, Kivisto KT. (1988). Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. Eur J Clin Pharmacol 35(5):495–501.
   Google Scholar
• Otaka H, Yasuhara A, Morita M. (2003). Determination of bisphenol A and 4-nonylphenol in human milk using alkaline digestion and cleanup by solid-phase extraction. Anal Sci 19(12):1663–6.
   Google Scholar
• Patel DK, Notarianni LJ, Bennett PN. (1990). Comparative metabolism of high doses of aspirin in man and rat. Xenobiotica 20(8):847–54.
   Google Scholar
• Pritchard M, Fournel-Gigleux S, Siest G, Mackenzie P, Magdalou J. (1994). A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol Pharmacol 45(1):42–50.
   Google Scholar
• Rawlins MD, Henderson DB, Hijab AR. (1977). Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol 11(4):283–6.
   Google Scholar
• Teeguarden JG, Waechter JM, Jr., Clewell HJ, 3rd Covington, TR, Barton HA. (2005). Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol Sci 85(2):823–38.
   PubMedGoogle Scholar
• Thompson PJ, Burgess KR, Marlin GE. (1980). Influence of food on absorption of erythromycin ethyl succinate. Antimicrob Agents Chemother 18(5):829–31.
   Google Scholar
• Uchaipichat V, Mackenzie PI, Guo XH, Gardner-Stephen D, Galetin A, Houston JB, Miners JO. (2004). Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 32(4):413–23.
   Google Scholar
• Vivacqua A, Recchia AG, Fasanella G, Gabriele S, Carpino A, Rago V, Di Gioia ML, Leggio A, Bonofiglio D, Liguori A, Maggiolini M. (2003). The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine 22(3):275–84.
   Google Scholar
• Yokota H, Iwano H, Endo M, Kobayashi T, Inoue H, Ikushiro S, Yuasa A. (1999). Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver. Biochem J 340(Pt 2):405–9.
   Google Scholar